These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1344442)

  • 61. ¹³¹I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma.
    Castro G; Berrocal I; Carmona J; González J; González P
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1356-7. PubMed ID: 22460690
    [No Abstract]   [Full Text] [Related]  

  • 62. Radiation safety precautions in the management of the hospitalized (131)I therapy patient.
    Thompson MA
    J Nucl Med Technol; 2001 Jun; 29(2):61-6; test 74-5. PubMed ID: 11376097
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outpatient treatment of thyroid cancer using high doses of iodine 131.
    Caldwell CB; Ehrlich LE
    Can Assoc Radiol J; 1999 Oct; 50(5):331-6. PubMed ID: 10555509
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Investigation on low-iodine diet implementation by medical staff before radioactive iodine treatment for differentiated thyroid carcinoma.
    Yi Y; Zhu Y; Wu Y; Hu F
    Ann Nucl Med; 2024 Aug; 38(8):639-646. PubMed ID: 38874877
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Radiotherapy of undifferentiated thyroid neoplasms].
    Tatsuno I; Sugihara M; Watanabe K
    Rinsho Hoshasen; 1977 May; 22(5):471-6. PubMed ID: 559169
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparison of measured and calculated dose rates near nuclear medicine patients.
    Yi Y; Stabin MG; McKaskle MH; Shone MD; Johnson AB
    Health Phys; 2013 Aug; 105(2):187-91. PubMed ID: 23799503
    [TBL] [Abstract][Full Text] [Related]  

  • 67. THE COMPARISON OF THE EXTERNAL DOSE RATE MEASUREMENT OF CHILDREN AND ADOLESCENT PATIENTS WITH ADULT PATIENTS TREATED WITH RADIOIODINE THERAPY.
    Edis N; Tamam MO
    Radiat Prot Dosimetry; 2019 Aug; 184(2):168-173. PubMed ID: 30452694
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Survey of radioiodine therapy safety practices highlights the need for user-friendly recommendations.
    Kloos RT
    Thyroid; 2011 Feb; 21(2):97-9. PubMed ID: 21275762
    [No Abstract]   [Full Text] [Related]  

  • 69. Outcome of pregnancy in women with thyroid carcinoma.
    Schlumberger M; De Vathaire F; Ceccarelli C; Francese C; Pinchera A; Parmentier C
    J Endocrinol Invest; 1995 Feb; 18(2):150-1. PubMed ID: 7629385
    [No Abstract]   [Full Text] [Related]  

  • 70. External radiotherapy and radionuclide in the treatment of thyroid cancer.
    Tubiana M
    World J Surg; 1981 Jan; 5(1):75-84. PubMed ID: 7233957
    [No Abstract]   [Full Text] [Related]  

  • 71. Painless thyroiditis and radioactive iodine therapy.
    Park HM
    Thyroid; 2009 Sep; 19(9):1013. PubMed ID: 19678744
    [No Abstract]   [Full Text] [Related]  

  • 72. Letter: Medullary thyroid carcinoma.
    Greenfield LD; Small RC; Byfield JE
    JAMA; 1974 Sep; 229(14):1864. PubMed ID: 4479194
    [No Abstract]   [Full Text] [Related]  

  • 73. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
    Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
    Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Radioiodine therapy in differentiated thyroid carcinoma.
    Salvatori M; Rufini V; Garganese MC; Di Giuda D
    Rays; 2000; 25(2):221-38. PubMed ID: 11370540
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Dosimetric measurements and early complications in patients with differentiated thyroid carcinomas treated with radioactive iodine].
    Malesević M; Stefanović L; Adzić O; Mihoci Z; Elez D
    Med Pregl; 1992; 45(11-12):427-31. PubMed ID: 1344442
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
    Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
    J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R; Legal JD; Schlumberger M; Voisin P; Aubert B; Gaillard N; Parmentier C
    J Nucl Med; 1996 Nov; 37(11):1860-4. PubMed ID: 8917193
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.